161 related articles for article (PubMed ID: 9250900)
1. Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.
Ikeda K; Saitoh S; Suzuki Y; Tsubota A; Koida I; Kobayashi M; Arase Y; Chayama K; Murashima N; Kumada H
J Gastroenterol; 1997 Aug; 32(4):513-20. PubMed ID: 9250900
[TBL] [Abstract][Full Text] [Related]
2. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
Ikeda K; Saitoh S; Kumada H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
[TBL] [Abstract][Full Text] [Related]
3. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
Maeda H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.
Tashiro S; Maeda H
Jpn J Med; 1985 Feb; 24(1):79-80. PubMed ID: 2987585
[No Abstract] [Full Text] [Related]
5. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
6. A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma.
Seymour LW; Olliff SP; Poole CJ; De Takats PG; Orme R; Ferry DR; Maeda H; Konno T; Kerr DJ
Int J Oncol; 1998 Jun; 12(6):1217-23. PubMed ID: 9592177
[TBL] [Abstract][Full Text] [Related]
7. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
8. Multiple hepatic infarction after transcatheter arterial infusion with SMANCS.
Abe S; Yamasaki T; Nakano K; Yoshikawa I; Tabaru A; Otsuki M
J Gastroenterol; 2001 Jun; 36(6):415-21. PubMed ID: 11428589
[TBL] [Abstract][Full Text] [Related]
9. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
10. Focal therapeutic efficacy of transcatheter arterial infusion of styrene maleic acid neocarzinostatin for hepatocellular carcinoma.
Abe S; Okubo Y; Ejiri Y; Kume K; Otsuki M
J Gastroenterol; 2000; 35(1):28-33. PubMed ID: 10632537
[TBL] [Abstract][Full Text] [Related]
11. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
[TBL] [Abstract][Full Text] [Related]
12. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
Maki S; Konno T; Iwai K; Uchida M; Tashiro S; Miyauchi Y; Maeda H
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1443-9. PubMed ID: 6097616
[No Abstract] [Full Text] [Related]
13. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
Okusaka T; Okada S; Ishii H; Ikeda M; Nakasuka H; Nagahama H; Iwata R; Furukawa H; Takayasu K; Nakanishi Y; Sakamoto M; Hirohashi S; Yoshimori M
Oncology; 1998; 55(4):276-83. PubMed ID: 9663415
[TBL] [Abstract][Full Text] [Related]
15. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
[TBL] [Abstract][Full Text] [Related]
16. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
Abe S; Otsuki M
Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
[TBL] [Abstract][Full Text] [Related]
17. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
Yoshida H; Onda M; Tajiri T; Uchida E; Arima Y; Mamada Y; Yamamoto K; Kaneko M; Terada Y; Kumazaki T
Hepatogastroenterology; 1999; 46(28):2612-5. PubMed ID: 10522050
[TBL] [Abstract][Full Text] [Related]
18. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
Noda S; Konno S; Tanaka J; Yamada M; Yoshitake N
Anticancer Res; 1990; 10(3):709-15. PubMed ID: 2164351
[TBL] [Abstract][Full Text] [Related]
19. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].
Kubo M; Fuchigami T; Murata S; Konno T; Maeda H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
Tsuchiya K; Uchida T; Kobayashi M; Maeda H; Konno T; Yamanaka H
Urology; 2000 Apr; 55(4):495-500. PubMed ID: 10736490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
